HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Malaria vaccine trials: the missing qualitative data.

Abstract
Recent population-based efficacy trials of the synthetic malaria vaccine SPf66 have shown restricted, if any, clinical protection against Plasmodium falciparum infection. Despite the well-established role of antibodies in effector responses against asexual blood-stage malaria parasites, the titres of anti-SPf66 IgG antibodies do not correlate with the ability of sera from vaccine recipients to inhibit parasite growth in vitro nor with partial clinical protection which could be detected in some trials. Qualitative or functional parameters of SP66-induced antibody responses, such as IgG subclass composition and affinity, may be more predictive of clinical protection against malaria than quantitative estimates of antibody concentration or titre. Since these parameters are readily estimated by laboratory techniques currently available, and may be modulated by changes in vaccination protocols and by the use of different adjuvants, a better understanding of qualitative antibody responses induced by SPf66 and other asexual blood-stage malaria vaccine candidates, and of their relationship with clinical protection in vivo, is urgently needed for the improvement of currently used immunization schedules.
AuthorsM Ferreira
JournalImmunology and cell biology (Immunol Cell Biol) Vol. 74 Issue 4 Pg. 301-5 (Aug 1996) ISSN: 0818-9641 [Print] United States
PMID8872178 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Antibodies, Protozoan
  • Malaria Vaccines
  • Protozoan Proteins
  • Recombinant Proteins
  • SPf66 protein, Plasmodium
  • Vaccines, Synthetic
Topics
  • Animals
  • Antibodies, Protozoan (immunology)
  • Clinical Trials as Topic
  • Humans
  • Immunologic Memory
  • Malaria Vaccines (immunology)
  • Malaria, Falciparum (prevention & control)
  • Plasmodium falciparum (immunology)
  • Protozoan Proteins (immunology)
  • Recombinant Proteins
  • Vaccines, Synthetic (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: